Arcellx (ACLX) Interest Coverage Ratio (2021 - 2025)
Arcellx's (ACLX) quarterly Interest Coverage Ratio came in at 5306.92 in Q4 2025, up 169.89% year-on-year from 1966.32 in Q4 2024, and up 985.6% quarter-over-quarter from 599.24 in Q2 2025.
Arcellx (ACLX) Interest Coverage Ratio (2021 - 2025) Analysis & Trends
Arcellx's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 5306.92 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 169.89% year-over-year to 5306.92 in Q4 2025; TTM through Dec 2025 was 2321.86, a 1638.39% decrease from a year earlier, with the FY2025 full-year figure at 0.83, down 151.01% from the prior year.
- Interest Coverage Ratio rose to 5306.92 in Q4 2025 per ACLX's latest filing, from 599.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 5306.92 in Q4 2025 and bottomed at 7593.14 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 1.08 (2022), against an average of 261.18.
- Across the five-year window, Interest Coverage Ratio tumbled 126088.14% in 2024 and surged 169.89% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.53 in 2021, then tumbled by 14048.51% to 75.62 in 2022, then soared by 111.41% to 8.63 in 2023, then plunged by 88085.08% to 7593.14 in 2024, then jumped by 169.89% to 5306.92 in 2025.
- Per Business Quant, the three latest ACLX Interest Coverage Ratio figures stand at 5306.92 (Q4 2025), 599.24 (Q2 2025), and 791.93 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 5,306.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,306.92 |
| Jun 30, 2025 | -599.24 |
| Mar 31, 2025 | -791.93 |
| Dec 31, 2024 | -7,593.14 |
| Sep 30, 2024 | -294.88 |
| Jun 30, 2024 | -109.01 |
| Mar 31, 2024 | -26.89 |
| Dec 31, 2023 | 8.63 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -75.62 |
| Sep 30, 2022 | -1.57 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.58 |
| Dec 31, 2021 | -0.53 |